EXECUTIVE COMMITTEE ON GLOBAL HEALTH AND HUMAN SECURITY

2007–Present

The Executive Committee on Global Health and Human Security is a unique public-private platform that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field. Under the chairmanship of Professor Keizo Takemi, the committee holds quarterly meetings to provide a venue for unofficial exchanges of views and information sharing among government ministries, academia, private companies, and civil society organizations in Japan. Global health experts from Japan and overseas are invited to speak at the meetings to offer their knowledge and advice.

The committee was initially launched in 2007 as the Working Group on Challenges in Global Health and Japan’s Contributions to prepare policy recommendations for the G8 Hokkaido Toyako Summit the following year. The committee is an integral part of the Global Health and Human Security Program of JCIE, which manages all aspects of the committee’s work.

WORKING GROUPS

In addition to its regular meetings, the following is a select list of some of the working groups and task forces established under the Executive Committee’s auspices:

PROGRAM ACTIVITIES


Launch of the G7 Global Health Task Force

August 10, 2022 | Japan

Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government o…


Briefing on the ACT-Accelerator at the Special Session of the Executive Committee on Global Health and Human Security

May 19, 2021 | Virtual

On May 19th, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joine…


Reformulating Japan's Global Health ODA to Meet Changing Global Needs

January 30, 2020 | Bangkok, Thailand

More than 30 senior government officials, health experts, and leaders from international organizations gathered to discuss the direction Japan should take to improve its developmental assistance for h…


Policy Recommendations for the 2016 G7 Summit in Japan: Toward Resilient and Sustainable Universal Health Coverage (UHC)

January 27, 2016 | Bangkok, Thailand

At this side event to the 2016 Prince Mahidol Award Conference (PMAC), members of JCIE’s Global Health Working Group (GHWG) presented their draft policy recommendations for the G7 Ise-Shima Summit in…


Dissemination Seminar in Africa—Global Action for Health System Strengthening

April 17–18, 2009 | Nairobi, Kenya

A final dissemination seminar for the Global Action for Health System Strengthening report was held in Nairobi, in collaboration with the African Medical and Research Foundation (AMREF), on April 17–1…


Dissemination Seminars in the United States—Global Action for Health System Strengthening

March 17–19, 2009 |

Two dissemination seminars for Global Action for Health System Strengthening were organized in Washington DC, one on March 17, 2009, that was organized in collaboration with the Center for Global Deve…


Dissemination Seminar in Asia—Global Action for Health System Strengthening

January 27, 2009 | Bangkok, Thailand

The primary goal of this seminar was to share with a broad group of global health stakeholders the outcomes of a recent report produced by an international task force of global health experts.


International Conference on Global Action for Health System Strengthening

November 3–4, 2008 | Tokyo, Japan

A high-level international conference was convened in Tokyo on November 3–4, 2008, to explore the creation of a global strategic framework for strengthening health systems in developing countries arou…

REPORTS


A COVID-19 Emergency Response Strategy—Establishing Domestic Vaccine Development Capacity During a Public Health Emergency

Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia, Executive Committee on Global Health and Human Security

2021

This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19…


Japan’s Global Health Diplomacy in the Post-COVID Era—The Paradigm Shift Needed on ODA and Related Policies

Special Commission on Japan’s Strategy on Development Assistance for Health

2020 & 2021

A report from a high-level commission organized by JCIE calls for the Japanese government to better coordinate and strategize its health ODA by creating a centralized “control tower” and to double fun…


Survey of Japanese Legislators: Attitudes on ODA and Global Health

Japan Center for International Exchange (JCIE)

June 2020

A JCIE survey of Japanese legislators finds that 80 percent of the 92 respondents favor steps to increase Japan’s official development assistance (ODA), with most prioritizing funding for health progr…


A UHC Approach to Harmonizing Asian Pharmaceutical and Medical Device Regulations

Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia, Executive Committee on Global Health and Human Security

2020

The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia examines specific areas Japan should tackle in order to promote regulatory har…


Recommendations on Formulating a Grand Design for Asian Pharmaceutical and Medical Device Regulatory Harmonization

Executive Committee on Global Health and Human Security, JCIE

2019

The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia highlight a need for regulatory harmonization and cross-sectoral cooperation.


Advancing a Global Health Agenda in the SDG Era: Enhancing Japan’s Leadership Role in 2019–2020

International Advisory Group on Global Health (IAG)

November 2018

This report details the insights from an ad hoc, 15-member “JCIE International Advisory Group on Global Health (IAG)” on the topic of supporting countries in implementing universal health coverage and…


Protecting Human Security: Proposals for the G7 Ise-Shima Summit in Japan

Global Health Working Group for the 2016 G7 Summit

May 21, 2016

This article shares policy recommendations to develop: global structures that enable effective preparedness for health emergencies, knowledge-sharing platforms for health system resilience and sustain…


Global Action for Health System Strengthening: Policy Recommendations to the G8

Task Force on Global Action for Health System Strengthening

2009

This report was submitted to the Japanese and Italian governments in January 2009 for consideration for the 2009 G8 Summit agenda.

EXECUTIVE COMMITTEE MEMBERS

CHAIR

Keizo Takemi

Member, House of Councillors; Senior Fellow, Japan Center for International Exchange (JCIE)

DIRECTOR

Akio Okawara

President and CEO, JCIE

SENIOR ADVISORS

Ichiro Aisawa

Member, House of Representatives

Katsunobu Kato

Member, House of Representatives

Norihisa Tamura

Member, House of Representatives

MEMBERS

Takeshi Akahori

Director-General for Global Issues, Ministry of Foreign Affairs

Yasuhiro Fujiwara

Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

Yasumasa Fukushima

Medical Commissioner, Ministry of Health, Labour and Welfare

Motohisa Furukawa

Member, House of Representatives

Noriko Furuya

Member, House of Representatives

Haruhiko Hirate

Executive Vice President, Dentsu Group, Inc.

Takashiro Ikeda

Director-General, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Naoki Ikegami

Professor emeritus, Keio University; Adjunct Professor, Kurume University School of Medicine

Hidetoshi Imamura

Executive Board Member, Japan Medical Association

Sachiko Imoto 

Vice President, Japan International Cooperation Agency (JICA)

Masaki Inaba 

Chair, Japan CSO Network on Global Health; Policy Advisor, Japan Civil Society Network on SDGs (SDGs Japan)

Sumie Ishii 

Chairperson, JOICFP (Japanese Organization for International Cooperation in Family Planning)

Masato Iwasaki

Representative Director and Member of the Takeda Board, Japan General Affairs, Takeda Pharmaceutical Company Ltd.

Masamine Jimba

Professor and Chair, Department of Community and Global Health, Graduate School of Medicine, University of Tokyo

Hiroshi Kasanuki

President, Medical Excellence JAPAN

Yasushi Katsuma

Professor, International Studies Program, Graduate School of Asia-Pacific Studies (GSAPS); Head of Global Health Affairs & Governance Group, Institute for Global Health Policy (iGHP), the National Center for Global Health & Medicine (NCGM)

Seiji Kihara

Deputy Chief Cabinet Secretary

Kiyoshi Kodera

Chair of the board, WaterAid Japan; Senior Research Associate, Overseas Development Institute

Norihiro Kokudo

President, National Center for Global Health and Medicine

Osamu Kunii 

Executive Director and CEO, Global Health Innovative Technology Fund (GHIT)

Kiyoshi Kurokawa

Adjunct Professor, National Graduate Institute for Policy Studies (GRIPS); Chairman, Health and Global Policy Institute

Kenichi Matsumoto

Vice Chairperson, The Japan Federation of Medical Devices Associations

Yoshiro Matsuo

Vice President and Representative Director, Otsuka Pharmaceutical Co., Ltd.

Haruo Naito

President and CEO, Eisai Co., Ltd.

Yasuhide Nakamura

Professor, School of Nursing, Konan Women’s University; President, WHO Association of Japan

Hiroki Nakatani

Visiting Professor, School of Medicine, Keio University

Kentaro Ogata

Deputy Vice Minister for International Affairs, Ministry of Finance (MOF)

Shigeru Omi

Representative Director, Japan Anti-Tuberculosis Association; Regional Director Emeritus, World Organization for Western Pacific Region (WPRO)

Tomohiro Onishi

Councillor, Office for COVID-19 and New Infectious Diseases Preparedness and Response, Cabinet Secretariat

Atsushi Seike

President, Japanese Red Cross Society

Johtaro Seki

President, International Total Engineering Corporation (ITEC)

Yasuhisa Shiozaki

Former Member, House of Representatives

Hideaki Shiroyama

Director, Institute for Future Initiatives; Professor, Graduate School of Public Policy; Professor, Graduate Schools for Law and Politics, University of Tokyo

Tomofumi Sone

President, National Institute of Public Health

Yukio Takasu

Special Adviser to the Secretary-General on Human Security, UN

Isao Teshirogi

President and CEO, Shionogi & Co., Ltd.

Kenji Yasukawa

President and CEO, Astellas Pharma Inc. 

 

as of July 2022

 

The Executive Committee was founded by and is organized by JCIE with the generous support of the Bill & Melinda Gates Foundation.